These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10906622)

  • 21. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
    Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M
    Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALLHAT: a saga of missed opportunities.
    McInnes GT
    J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
    [No Abstract]   [Full Text] [Related]  

  • 26. Trials and tribulations.
    Packard CJ
    Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
    [No Abstract]   [Full Text] [Related]  

  • 27. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers DG; Lee KW; Lip GY
    J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hypertriglyceridemia with a history of treatment failure.
    Capell WH; Eckel RH
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):53-8; quiz 59. PubMed ID: 16929366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 47-year-old man with eruptions on his trunk.
    Kreitzer T; Wright A; Shulbrook J
    J Fam Pract; 2006 Jul; 55(7):597-9. PubMed ID: 16822446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence trends for myocardial infarction and conventional risk factors among Greek adults (2002-06).
    Gikas A; Sotiropoulos A; Panagiotakos D; Pastromas V; Papazafiropoulou A; Pappas S
    QJM; 2008 Sep; 101(9):705-12. PubMed ID: 18603596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
    Nieuwdorp M; Stroes ES; Kastelein JJ;
    Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications.
    Chiuve SE; McCullough ML; Sacks FM; Rimm EB
    Circulation; 2006 Jul; 114(2):160-7. PubMed ID: 16818808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening, prevention and early therapy of type 2 diabetics].
    Hanefeld M; Köhler C
    MMW Fortschr Med; 2004 Sep; 146(35-36):28-9, 31. PubMed ID: 15540535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening and treatment recommendations for adults with hypercholesterolemia.
    Ennis ED; Kreisberg RA
    Compr Ther; 1996 Aug; 22(8):492-500. PubMed ID: 8879916
    [No Abstract]   [Full Text] [Related]  

  • 39. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
    Gaede PH; Jepsen PV; Larsen JN; Jensen GV; Parving HH; Pedersen OB
    Ugeskr Laeger; 2003 Jun; 165(26):2658-61. PubMed ID: 12886549
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective whole blood lipoprotein apheresis to prevent pancreatitis in drug refractory hypertriglyceridemia.
    Hovland A; Hardersen R; Mollnes TE; Lappegård KT
    JOP; 2010 Sep; 11(5):467-9. PubMed ID: 20818118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.